About Zymes Bioscience
Zymes Bioscience is a company based in Delhi (India) founded in 2012 by Ashok Kumar Papneja, Mohit Bhatia, and Chandan Chopra. It operates as a B2B. The company has 51 employees as of March 31, 2022. Zymes Bioscience offers products and services including Antibiotic Therapies and Innovative Products Pipeline.
- Headquarter Delhi, India
- Employees 51 as on 31 Mar, 2022
- Founders Ashok Kumar Papneja, Mohit Bhatia, Chandan Chopra
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Zymes Bioscience Private Limited
- Date of Incorporation 09 Apr, 2012
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$3.63 M (USD)126.94as on Mar 31, 2022
-
Net Profit
$174.09 K (USD)27.82as on Mar 31, 2022
-
EBITDA
$100.26 K (USD)135.17as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
51
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zymes Bioscience
Zymes Bioscience offers a comprehensive portfolio of products and services, including Antibiotic Therapies and Innovative Products Pipeline.
Therapies designed to treat acute illnesses and combat bacterial resistance effectively.
Upcoming solutions for overcoming bacterial resistance in medical applications.
Funding Insights of Zymes Bioscience
Detailed funding history for Zymes Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zymes Bioscience
Investment portfolio details for Zymes Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zymes Bioscience
Detailed financials for Zymes Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zymes Bioscience Comparisons
Peer comparison for Zymes Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zymes Bioscience
Detailed competitors of Zymes Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zymes Bioscience
Complete news archive for Zymes Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zymes Bioscience
Zymes Bioscience was founded in 2012.
Zymes Bioscience is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
As of Mar 31, 2022, the latest employee count at Zymes Bioscience is 51.
Annual revenue of Zymes Bioscience is $3.63M as on Mar 31, 2022.
Zymes Bioscience focuses on creating innovative therapies for acute and life-threatening conditions, particularly in antibiotic treatment to address bacterial resistance. The company supports the medical community through product development and pipeline innovations. Based in New Delhi, it emphasizes team growth, customer input, and reliable solutions. They aim to deliver effective medical treatments while fostering collaboration and career opportunities within a dedicated team.
Zymes Bioscience offers Antibiotic Therapies and Innovative Products Pipeline.